STREAMLINE HEALTH SOLUTIONS INC.: 10-Q filed 2013-09-13

Name: STREAMLINE HEALTH SOLUTIONS INC.: 10-Q filed 2013-09-13
Creator: STREAMLINE HEALTH SOLUTIONS INC.

What STREAMLINE HEALTH SOLUTIONS INC. reported in its quarterly report filed 2013-09-13 (fiscal Q2 2013): 37 published measures, 101 facts as tagged in accession 0001008586-13-000006.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-09-13
Fiscal period: fiscal Q2 2013
Accession: 0001008586-13-000006 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All STREAMLINE HEALTH SOLUTIONS INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-07-31	53,809,257	USD
At 2013-01-31	55,266,578	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2013-07-31	35,166,689	USD
At 2013-01-31	34,041,560	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2013-07-31	10,677,053	USD
At 2013-01-31	13,459,302	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-07-31	5,355,673	USD
At 2013-01-31	7,500,256	USD
At 2012-07-31	4,071,522	USD
At 2012-01-31	2,243,054	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	-828,203	USD	92
2013-02-01 to 2013-07-31	-3,538,050	USD	181
2012-05-01 to 2012-07-31	-463,269	USD	92
2012-02-01 to 2012-07-31	28,359	USD	182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2013-02-01 to 2013-07-31	-1,366,924	USD	181
2012-02-01 to 2012-07-31	3,168,214	USD	182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2013-02-01 to 2013-07-31	94,240	USD	181
2012-02-01 to 2012-07-31	448,768	USD	182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2013-02-01 to 2013-07-31	114,375	USD	181
2012-02-01 to 2012-07-31	79,022	USD	182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2013-02-01 to 2013-07-31	-892,034	USD	181
2012-02-01 to 2012-07-31	-1,418,768	USD	182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2013-07-31	-39,383,573	USD
At 2013-01-31	-35,845,523	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	12,861,715	shares	92
2013-02-01 to 2013-07-31	12,698,094	shares	181
2012-05-01 to 2012-07-31	11,316,083	shares	92
2012-02-01 to 2012-07-31	10,817,214	shares	182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	12,861,715	shares	92
2013-02-01 to 2013-07-31	12,698,094	shares	181
2012-05-01 to 2012-07-31	11,316,083	shares	92
2012-02-01 to 2012-07-31	10,936,752	shares	182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	-0.07	USD/shares	92
2013-02-01 to 2013-07-31	-0.31	USD/shares	181
2012-05-01 to 2012-07-31	-0.04	USD/shares	92
2012-02-01 to 2012-07-31	0	USD/shares	182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	-0.07	USD/shares	92
2013-02-01 to 2013-07-31	-0.31	USD/shares	181
2012-05-01 to 2012-07-31	-0.04	USD/shares	92
2012-02-01 to 2012-07-31	0	USD/shares	182

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	143,874	USD	92
2013-02-01 to 2013-07-31	163,624	USD	181
2012-05-01 to 2012-07-31	24,000	USD	92
2012-02-01 to 2012-07-31	33,000	USD	182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2013-07-31	955,006	USD
At 2013-01-31	1,198,805	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	359,000	USD	92
2013-02-01 to 2013-07-31	825,531	USD	181
2012-05-01 to 2012-07-31	222,000	USD	92
2012-02-01 to 2012-07-31	399,961	USD	182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	967,642	USD	92
2013-02-01 to 2013-07-31	-413,625	USD	181
2012-05-01 to 2012-07-31	-24,293	USD	92
2012-02-01 to 2012-07-31	648,120	USD	182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-07-31	20,022,314	USD
At 2013-01-31	19,877,778	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	587,808	USD	92
2013-02-01 to 2013-07-31	1,154,373	USD	181
2012-05-01 to 2012-07-31	391,188	USD	92
2012-02-01 to 2012-07-31	599,018	USD	182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-07-31	16,630,553	USD
At 2013-01-31	17,325,422	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2013-07-31	1,605,745	USD
At 2013-01-31	1,495,913	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2013-07-31	12,166,959	USD
At 2013-01-31	12,133,304	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2013-07-31	10,773,182	USD
At 2013-01-31	8,685,017	USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	3,408,153	USD	92
2013-02-01 to 2013-07-31	6,989,020	USD	181
2012-05-01 to 2012-07-31	2,204,205	USD	92
2012-02-01 to 2012-07-31	3,873,965	USD	182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	1,160,147	USD	92
2013-02-01 to 2013-07-31	2,257,157	USD	181
2012-05-01 to 2012-07-31	510,842	USD	92
2012-02-01 to 2012-07-31	967,205	USD	182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-07-31	12,643,620	shares

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2013-07-31	13,063,000	USD
At 2013-01-31	13,688,000	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2013-07-31	7,251,772	USD
At 2013-01-31	7,157,532	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2013-07-31	6,296,766	USD
At 2013-01-31	5,958,727	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2013-07-31	7,559,154	USD
At 2013-01-31	8,188,131	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	-843,713	USD	92
2013-02-01 to 2013-07-31	-3,895,196	USD	181
2012-05-01 to 2012-07-31	-463,269	USD	92
2012-02-01 to 2012-07-31	28,359	USD	182

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2013-02-01 to 2013-07-31	338,039	USD	181
2012-02-01 to 2012-07-31	362,631	USD	182

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2013-02-01 to 2013-07-31	628,977	USD	181
2012-02-01 to 2012-07-31	25,318	USD	182

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	-1,064,163	USD	92
2013-02-01 to 2013-07-31	-1,806,428	USD	181
2012-05-01 to 2012-07-31	-23,788	USD	92
2012-02-01 to 2012-07-31	12,257	USD	182

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2013-02-01 to 2013-07-31	133,324	USD	181
2012-02-01 to 2012-07-31	0	USD	182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2013-02-01 to 2013-07-31	89,856	USD	181
2012-02-01 to 2012-07-31	-167,998	USD	182

Inspect the source

Entity: STREAMLINE HEALTH SOLUTIONS INC. / CIK 0001008586
Captured: 2026-09-21T17:17:56.440Z
SEC response SHA-256: f28ec2b62f459f9e1502e7518fb1b41cf9eab0c85e2282d838d54aa5e44579c9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001008586.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))